BANK VONTOBEL AG | Market Closed - Swiss Exchange 08:50:00 27/06/2024 pm IST | ||
| 100.9 USD | +0.20% |
|
| 1 month | +2.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 100.9 | +0.20% |
| 25/24/25 | 100.7 | +0.10% |
Delayed Quote Swiss Exchange
Last update June 27, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| RBIADV | |
| ISIN | CH1333291909 |
| Date issued | 17/04/2024 |
| Strike | 194.4 $ |
| Maturity | 17/04/2025 (294 Days) |
| Parity | 0.19 : 1 |
| Emission price | 98 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 100.9 $ |
|---|---|
| Lowest since issue | 97.9 $ |
| Spread | 5 $ |
| Spread % | 0.49% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.7
USD
Average target price
283.2
USD
Spread / Average Target
+23.80%
- Stock Market
- Certificates
- RBIADV Certificat
